Sequana Medical Toekomstige groei
Future criteriumcontroles 2/6
Sequana Medical is forecast to grow earnings and revenue by 55.6% and 101.6% per annum respectively while EPS is expected to grow by 67.4% per annum.
Belangrijke informatie
55.6%
Groei van de winst
67.4%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 19.0% |
| Inkomstengroei | 101.6% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 23 Oct 2024 |
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 23 | -6 | N/A | -5 | 1 |
| 12/31/2025 | 16 | -11 | N/A | -5 | 2 |
| 12/31/2024 | 1 | -19 | -35 | -13 | 2 |
| 6/30/2024 | 0 | -27 | -26 | -25 | N/A |
| 3/31/2024 | 1 | -30 | -28 | -27 | N/A |
| 12/31/2023 | 1 | -33 | -30 | -29 | N/A |
| 9/30/2023 | 1 | -32 | -30 | -30 | N/A |
| 6/30/2023 | 1 | -32 | -30 | -30 | N/A |
| 3/31/2023 | 1 | -32 | -29 | -29 | N/A |
| 12/31/2022 | 1 | -31 | -28 | -27 | N/A |
| 9/30/2022 | 1 | -29 | -27 | -26 | N/A |
| 6/30/2022 | 1 | -27 | -26 | -25 | N/A |
| 3/31/2022 | 1 | -25 | -25 | -25 | N/A |
| 12/31/2021 | 0 | -24 | -24 | -24 | N/A |
| 9/30/2021 | 0 | -23 | -22 | -22 | N/A |
| 6/30/2021 | 0 | -21 | -20 | -20 | N/A |
| 3/31/2021 | 1 | -20 | -18 | -18 | N/A |
| 12/31/2020 | 1 | -19 | -17 | -17 | N/A |
| 9/30/2020 | 1 | -18 | -16 | -16 | N/A |
| 6/30/2020 | 1 | -17 | -16 | -16 | N/A |
| 3/31/2020 | 1 | -16 | -17 | -17 | N/A |
| 12/31/2019 | 1 | -15 | -19 | -18 | N/A |
| 9/30/2019 | 1 | -16 | -19 | -19 | N/A |
| 6/30/2019 | 1 | -16 | -18 | -18 | N/A |
| 3/31/2019 | 1 | -15 | -14 | -14 | N/A |
| 12/31/2018 | 1 | -14 | -10 | -10 | N/A |
| 9/30/2018 | 1 | -10 | -8 | -8 | N/A |
| 12/31/2017 | 1 | -8 | N/A | -8 | N/A |
| 12/31/2016 | 1 | -14 | N/A | -13 | N/A |
| 12/31/2015 | 2 | -12 | N/A | -11 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: SEQUA is forecast to remain unprofitable over the next 3 years.
Winst versus markt: SEQUA is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: SEQUA is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: SEQUA's revenue (101.6% per year) is forecast to grow faster than the Belgian market (7.2% per year).
Hoge groei-inkomsten: SEQUA's revenue (101.6% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if SEQUA's Return on Equity is forecast to be high in 3 years time